Illumina, Inc. (ILMN)
223.19
+3.79
(+1.73%)
USD |
NASDAQ |
Aug 24, 16:00
223.75
+0.56
(+0.25%)
After-Hours: 20:00
Illumina Shareholders Equity (Quarterly) : 2.838B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.838B |
| March 31, 2026 | 2.676B |
| December 31, 2025 | 2.723B |
| September 30, 2025 | 2.381B |
| June 30, 2025 | 2.258B |
| March 31, 2025 | 2.368B |
| December 31, 2024 | 2.373B |
| September 30, 2024 | 2.125B |
| June 30, 2024 | 1.436B |
| March 31, 2024 | 5.734B |
| December 31, 2023 | 5.745B |
| September 30, 2023 | 5.898B |
| June 30, 2023 | 6.555B |
| March 31, 2023 | 6.693B |
| December 31, 2022 | 6.599B |
| September 30, 2022 | 6.731B |
| June 30, 2022 | 10.44B |
| March 31, 2022 | 10.90B |
| December 31, 2021 | 10.74B |
| September 30, 2021 | 10.59B |
| June 30, 2021 | 5.18B |
| March 31, 2021 | 4.922B |
| December 31, 2020 | 4.694B |
| September 30, 2020 | 4.70B |
| June 30, 2020 | 4.563B |
| Date | Value |
|---|---|
| March 31, 2020 | 4.635B |
| December 31, 2019 | 4.613B |
| September 30, 2019 | 4.439B |
| June 30, 2019 | 4.332B |
| March 31, 2019 | 3.985B |
| December 31, 2018 | 3.758B |
| September 30, 2018 | 3.503B |
| June 30, 2018 | 3.257B |
| March 31, 2018 | 3.008B |
| December 31, 2017 | 2.749B |
| September 30, 2017 | 2.855B |
| June 30, 2017 | 2.715B |
| March 31, 2017 | 2.551B |
| December 31, 2016 | 2.197B |
| September 30, 2016 | 2.240B |
| June 30, 2016 | 2.056B |
| March 31, 2016 | 1.991B |
| December 31, 2015 | 1.849B |
| September 30, 2015 | 1.937B |
| June 30, 2015 | 1.794B |
| March 31, 2015 | 1.623B |
| December 31, 2014 | 1.463B |
| September 30, 2014 | 1.274B |
| June 30, 2014 | 1.080B |
| March 31, 2014 | 1.574B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 7.122B |
| Thermo Fisher Scientific, Inc. | 52.68B |
| Danaher Corp. | 52.58B |
| Bio-Rad Laboratories, Inc. | 7.174B |
| Pacific Biosciences of California, Inc. | -33.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.65B |
| Total Liabilities (Quarterly) | 3.812B |
| Debt to Equity Ratio | 0.8904 |
| Current Ratio | 1.796 |
| Net Debt Paydown Yield | 0.06% |